Axelopran

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameAxelopran
Drug Alias Name阿西洛仑axelopranum阿赛普兰TD-1211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsOpioid-Induced ConstipationConstipationProstatic Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTheravance Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesGlycyx MOR IncHealthpartners Institute
Inactive CompaniesTheravance Biopharma Inc
Active IndicationsProstatic NeoplasmsLung NeoplasmsPancreatic Neoplasms +[4] 
Inactive IndicationsOpioid-Induced ConstipationConstipation

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG